IGSF21
Basic information
Region (hg38): 1:18107798-18378483
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IGSF21 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 38 | 43 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 3 | 3 |
Variants in IGSF21
This is a list of pathogenic ClinVar variants found in the IGSF21 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-18227930-C-T | not specified | Uncertain significance (Feb 12, 2024) | ||
1-18227931-C-A | not specified | Uncertain significance (Oct 12, 2021) | ||
1-18227948-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
1-18227985-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
1-18291882-C-A | not specified | Uncertain significance (Aug 02, 2021) | ||
1-18291950-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
1-18291951-G-T | not specified | Uncertain significance (Dec 28, 2022) | ||
1-18334899-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
1-18334960-C-T | not specified | Uncertain significance (Dec 10, 2024) | ||
1-18362168-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
1-18362169-G-A | not specified | Uncertain significance (Nov 20, 2023) | ||
1-18362190-C-A | not specified | Uncertain significance (Nov 17, 2023) | ||
1-18365223-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
1-18365256-G-T | not specified | Uncertain significance (May 01, 2022) | ||
1-18365266-T-C | not specified | Uncertain significance (Jul 21, 2022) | ||
1-18365308-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
1-18365320-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
1-18365334-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
1-18365382-G-A | not specified | Likely benign (Nov 02, 2023) | ||
1-18365392-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
1-18365404-C-A | not specified | Uncertain significance (Oct 05, 2023) | ||
1-18365416-G-A | Benign (Apr 05, 2018) | |||
1-18365422-C-T | not specified | Uncertain significance (Sep 05, 2024) | ||
1-18365425-G-A | not specified | Likely benign (Aug 02, 2022) | ||
1-18365461-C-T | not specified | Uncertain significance (Sep 26, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IGSF21 | protein_coding | protein_coding | ENST00000251296 | 10 | 270738 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.209 | 0.791 | 125740 | 0 | 8 | 125748 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.324 | 296 | 312 | 0.948 | 0.0000215 | 2998 |
Missense in Polyphen | 125 | 139.36 | 0.89697 | 1216 | ||
Synonymous | 0.265 | 129 | 133 | 0.971 | 0.00000961 | 1004 |
Loss of Function | 3.11 | 5 | 20.0 | 0.249 | 0.00000102 | 221 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000537 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in synaptic inhibition in the brain. Selectively regulates inhibitory presynaptic differentiation through interacting with presynaptic NRXN2. {ECO:0000250|UniProtKB:Q7TNR6}.;
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- 0.336
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 18.19
Haploinsufficiency Scores
- pHI
- 0.245
- hipred
- Y
- hipred_score
- 0.579
- ghis
- 0.586
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Igsf21
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- homophilic cell adhesion via plasma membrane adhesion molecules;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;synapse maturation
- Cellular component
- cell-cell adherens junction;anchored component of external side of plasma membrane;presynaptic membrane;postsynaptic membrane;inhibitory synapse
- Molecular function
- signaling receptor activity;protein homodimerization activity;cell adhesion molecule binding